This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 1987-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Caldwell, NJ (US) (1987 - 1990)
- North Caldwell, NJ (US) (1998 - 2017)
Company Filing History:
Years Active: 1987-2017
Areas of Expertise:
Title: Allen John Lovey: Innovator in Pharmaceutical Compounds
Introduction
Allen John Lovey, based in North Caldwell, NJ, is a prolific inventor with an impressive portfolio of 24 patents. His work primarily focuses on developing novel pharmaceutical compounds and methods that address various medical conditions. As an integral member of Hoffmann-La Roche Inc., Lovey continues to push the boundaries of innovation in the pharmaceutical industry.
Latest Patents
Among Lovey's notable recent inventions are two significant patents. The first is for substituted sulfonamide compounds. This invention involves compounds of a specific formula, which are described in detail, including their salts. The primary application of these compounds lies in their potential to treat diseases mediated by TRPA1, such as pain. The second patent relates to pyrrolopyrazine kinase inhibitors, which are novel derivatives designed to inhibit JAK and SYK pathways. These inhibitors hold promise for the treatment of autoimmune and inflammatory diseases.
Career Highlights
Lovey's career has been marked by significant contributions to pharmaceutical science. Working at Hoffmann-La Roche Inc., he has developed therapeutic solutions that address critical health issues. His work not only demonstrates his technical expertise but also his commitment to improving patient care through innovative treatments.
Collaborations
Throughout his career, Lovey has collaborated with esteemed colleagues, including Qingjie Ding and Michael Rosenberger. These professional partnerships have fostered an environment of creativity and knowledge exchange, enabling Lovey to enhance his inventions and impact the pharmaceutical field.
Conclusion
In summary, Allen John Lovey is a distinguished inventor whose 24 patents reflect his dedication to advancing pharmaceutical innovation. His latest work on substituted sulfonamide compounds and pyrrolopyrazine kinase inhibitors showcases his ability to develop solutions for complex medical challenges. As part of Hoffmann-La Roche Inc., Lovey continues to collaborate with talented professionals to drive meaningful advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile